ALLO
ALLOGENE THERAP (ALLO)
NASDAQ
$1.27-$0.06 (-4.36%)
Price as of Oct 22, 2026 7:57 PM EDT
  • $459.5M
    Market Cap
  • 9.92%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 47
Valuation
ALLO
vs History
vs S&P 500
Profitability
-1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 42
Valuation
ALLO
vs History
vs S&P 500
3-Month Momentum
-7.57%
12-Month Momentum
35.71%
3-Month Risk Adjusted Momentum
-28.74%
12-Month Risk Adjusted Momentum
44.02%

True Yield

N/A
Valuation
ALLO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.0006%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
ALLO
vs History
vs S&P 500
Ohlson's O-Score
5